Novavax, Inc. (NASDAQ:NVAX) Most Promising Medical Research Stock, Shayne Heffernan Says A mix of legacy drug makers and small startups have stepped forward with plans to develop vaccines or treatments that target the infection caused by the novel coronavirus. NovavaxTicker: NASDAQ:NVAXPrice: $44.96 Novavax Inc. US:NVAX, a preclinical biotechnology company, announced Feb. 26 that it had […]
Novavax (NASDAQ:NVAX) Technicals Bearish Divergence Overall, the bias in prices is: Upwards. Short term: Prices are moving. Intermediate term: Prices are trending. Note: this chart shows extraordinary price action to the upside. By the way, prices are vulnerable to a correction towards 1.42. The projected upper bound is: 2.70. The projected lower bound is: 1.81. […]
